Asset Details
Do you wish to reserve the book?
Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2
Do you wish to request the book?
Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2
2023
Overview
A wide range of endogenous and xenobiotic organic ions require facilitated transport systems to cross the plasma membrane for their disposition. In mammals, organic cation transporter (OCT) subtypes 1 and 2 (OCT1 and OCT2, also known as SLC22A1 and SLC22A2, respectively) are polyspecific transporters responsible for the uptake and clearance of structurally diverse cationic compounds in the liver and kidneys, respectively. Notably, it is well established that human OCT1 and OCT2 play central roles in the pharmacokinetics and drug–drug interactions of many prescription medications, including metformin. Despite their importance, the basis of polyspecific cationic drug recognition and the alternating access mechanism for OCTs have remained a mystery. Here we present four cryo-electron microscopy structures of apo, substrate-bound and drug-bound OCT1 and OCT2 consensus variants, in outward-facing and outward-occluded states. Together with functional experiments, in silico docking and molecular dynamics simulations, these structures uncover general principles of organic cation recognition by OCTs and provide insights into extracellular gate occlusion. Our findings set the stage for a comprehensive structure-based understanding of OCT-mediated drug–drug interactions, which will prove critical in the preclinical evaluation of emerging therapeutics.
Organic cation transporters (OCTs) are responsible for the hepatic uptake and renal clearance of well over 250 US Food and Drug Administration-approved drugs. Suo et al. solved cryo-electron microscopy structures of OCT variants in complex with xenobiotics, providing insights into drug recognition by OCTs.
Publisher
Nature Publishing Group US,Nature Publishing Group
